...will provide runway into 2022. The company entered into an $80 million debt facility with Hercules Capital...

...that includes GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Hercules Capital...
...head of clinical development at Zafgen Inc. (NASDAQ:ZFGN). BioCentury Staff Acacia Pharma Group plc Aurinia Pharmaceuticals Inc. Escient Pharmaceuticals Inc. Hercules Capital Immunic...

...will be a permanent capital base. The firm, whose founding managing director and CEO is Hercules Capital...
...declined to say from whom; its capital pool would also grow via returns. Paul Bonanos, Assistant Editor Hercules Capital K2...

...Metabolic Acidosis" ). The company also announced Thursday it amended its existing debt facility with Hercules Capital...

...discuss a potential NDA submission. Also on Tuesday, Aldeyra said it entered an agreement with Hercules Capital...

...NASDAQ:TGTX) also said it drew down $30 million of a $60 million loan facility with Hercules Capital. Shannon...

...Urology-focused biotech Urovant drew down $15 million under a newly announced loan facility with Hercules Capital. Urovant...

...said it closed a $30 million tranche of a $60 million debt financing agreement with Hercules Capital...

...co-led the new financing. Fellow existing investors Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Hercules Capital...